AletheiaHQ
Sign In
DIR-B8-MJZ-GGWO/LVL 2·Guided ArbitrageGuided multi-step solo arbitrage producing a concrete deliverable. Requires basic commercial judgment. Examples: formatting extracted data into a $99 compliance checklist and cold-emailing 500 affected businesses; translating a buried scientific abstract into a viral short-form script monetised via affiliate links./85% confidence
Return to Directory

Package FDA Bone Repair Clearance Data into $499 Reports for SBIR Companies

Organization
FDA 510(k) clearance database (public but unstructured data requiring expert interpretation)
Sector
SBIR-funded bone repair companies needing FDA regulatory intelligence for Phase II applications
Location
Location unspecified

Source Reference

https://www.nsf.gov/awardsearch/showAward?AWD_ID=2538047

// Biotech// Grant Writing// Data Scraping// Design// Health Policy & Regulation// Data Engineering & Pipelines

Executive Context

NSF awarded $305K SBIR Phase I funding to CYTROGEN for Gelatrix, a light-curable bone adhesive, creating a research-funded entity with technical validation capital but zero commercial infrastructure, manufacturing partnerships, or market access pathways.

Catalyst / Timing

SBIR Phase II applicants must demonstrate understanding of FDA regulatory pathways and competitive landscape, but have no budget for expensive consulting reports. They need specific, actionable data on predicate devices and manufacturer contacts to complete their commercialization plan.

Projected Yield

$349/report × 20 sales = $6,980 immediate revenue (scalable to 50+ companies)

Structural Friction

• Vulnerability: SBIR Phase II applicants must demonstrate understanding of FDA regulatory pathways and competitive landscape, but have no budget for expensive consulting reports. They need specific, actionable data on predicate devices and manufacturer contacts to complete their commercialization plan. • Capital yield: $349/report × 20 sales = $6,980 immediate revenue (scalable to 50+ companies) • Influence capture: Authority position as FDA regulatory pathway expert for bone repair biomaterials • Required vectors: Vector: Data Extraction, Vector: Product Packaging, Vector: Cold Email Sales

Required Capabilities

  • Vector: Data Extraction

    Primary executor: Phase 1: FDA-Cleared Product Extraction: Scrape FDA 510(k) database for all bone repair material clearances in last 5 ye

  • Vector: Product Packaging

    Supporting vector for: Package FDA Bone Repair Clearance Data into $499 Reports for SBIR Companies

  • Vector: Cold Email Sales

    Supporting vector for: Package FDA Bone Repair Clearance Data into $499 Reports for SBIR Companies

Execution Protocol

Execution Protocol Locked

A one-time payment of $49 unlocks the exact wedge, required assets, and step-by-step execution parameters yours forever, no subscription.

This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.